Page 3 - Nasdaq Ango News Today

AngioDynamics (NASDAQ:ANGO – Free Report) had its price target upped by Canaccord Genuity Group from $18.00 to $20.00 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. Other equities research analysts have also recently issued reports about the company. StockNews.com upgraded AngioDynamics from […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of -$0.34–$0.28 for the period, compared to the consensus EPS estimate of -$0.02. The company issued revenue guidance of $328.00 million-$333.00 million, compared to the consensus revenue estimate of $353.62 million. Analyst Ratings Changes A number […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02, MarketWatch Earnings reports. The business had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $90.73 million. AngioDynamics had a negative return on […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of ($0.34)-($0.28) for the period, compared to the consensus earnings per share estimate of ($0.03). The company issued revenue guidance of $328-333 million, compared to the consensus revenue estimate of $353.75 million. Analyst Ratings Changes […]

StockNews.com assumed coverage on shares of AngioDynamics (NASDAQ:ANGO – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Raymond James cut AngioDynamics from a strong-buy rating to an outperform rating and decreased their target price for the stock from $14.00 […]

Heartland Advisors Inc. lifted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 40.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 611,722 shares of the medical instruments supplier’s stock after purchasing an additional 175,383 shares during the quarter. […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Based on an average daily trading volume, of 336,700 shares, the […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a drop of 18.2% from the March 31st total of 923,300 shares. Currently, 2.0% of the shares of the company are sold short. Based on an […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 755,400 shares, a decrease of 18.2% from the March 31st total of 923,300 shares. Approximately 2.0% of the company’s stock are short sold. Based on […]

Raymond James downgraded shares of AngioDynamics (NASDAQ:ANGO – Get Rating) from a strong-buy rating to an outperform rating in a report released on Monday morning, Marketbeat.com reports. The brokerage currently has $13.00 price target on the medical instruments supplier’s stock, down from their previous price target of $14.00. Separately, StockNews.com assumed coverage on shares of […]